Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- Check7 days agoChange DetectedThe study page now clearly indicates recruitment is closed with a 'No longer looking for participants' note. The page also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading for consistency, reflecting navigation and terminology improvements.SummaryDifference0.4%

- Check14 days agoChange DetectedVersion label on the page updated from v3.5.4 to v3.5.5, indicating a new page revision. The change does not alter the study details or eligibility criteria shown on the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision label, v3.5.4, was added to the page's revision history, replacing the previous label v3.5.3.SummaryDifference0.1%

- Check57 days agoChange DetectedA site release/revision label displayed on the page footer was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded revision note indicating the current page version (v3.5.0) and removed the previous v3.4.3. This update reflects backend versioning rather than substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.